Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Insuman Implantable vs Insuplant in Medtronic MiniMed Implantable Pump for Type 1 Diabetes
2010-021373-37Phase 3Completed
- Sponsor
- Sanofi
- Start
- Jul 2010
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3 trial of human insulin in diabetes mellitus type 1 (T1D) (2 arms), sponsored by Sanofi. Primary endpoint: Overall benefit–risk of Insuman Implantable vs Insuplant. Started Jul 2010; status: completed.
02
Drugs
human insulin
03
Conditions
diabetes mellitus type 1 (T1D)
Beyond the preview
Go deeper on 2010-021373-37.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-021373-37.